OF SHARED RESOURCE The Sidney Kimmel Comprehensive Cancer Center (SKCCC) Research Pharmacy (Oncology Invesigational Drug Service) is an integral part of the SKCCC's research efforts. The Research Pharmacy staff works in close collaboration with the SKCCC Clinical Research Office, individual investigators and the JHH Pharmacy staff to coordinate and facilitate the development, implementation and maintenance of clinical protocols. Specifically, the Research Pharmacy is responsible for the management of inventory, storage, preparation and distribution of drugs and pharmaceutics used in clinical research for the SKCCC. Clinical and operational support includes, but is not limited to, assistance and collaboration in the development/ modification and support of investigational protocols in SKCCC, ongoing responsibilities for drug accountability and regulatory compliance. The Research Pharmacy is integrated with the SKCCC and the Johns Hopkins Pharmacy Department. The resource is available to investigators and the research team for patient care issues 24 hours a day, seven days a week to support SKCCC clinical trials. The Research Pharmacy works closely with the expanding efforts of the Center to facilitate the conduction of clinical trials. Lay: The Research Pharmacy provides and oversees the pharmacy services for individuals for in clinical trials. Additionally, this resource coordinates the operational aspects of drug therapy for clinical trials. This Core Facility is administered jointly by the Johns Hopkins Hospital Investigational Drug Service (IDS) and the SKCCC. Current Grant Year Reporting Period: January 2010 to December 2010.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006973-52
Application #
8858526
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
2016-04-30
Budget Start
2015-05-01
Budget End
2016-04-30
Support Year
52
Fiscal Year
2015
Total Cost
$246,153
Indirect Cost
$94,207
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Hyman, David M; Rizvi, Naiyer; Natale, Ronald et al. (2018) Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors. Clin Cancer Res 24:2749-2757
Guo, Hong; Barberi, Theresa; Suresh, Rahul et al. (2018) Progression from the Common Lymphoid Progenitor to B/Myeloid PreproB and ProB Precursors during B Lymphopoiesis Requires C/EBP?. J Immunol 201:1692-1704
Tosoian, Jeffrey J; Guedes, Liana B; Morais, Carlos L et al. (2018) PTEN status assessment in the Johns Hopkins active surveillance cohort. Prostate Cancer Prostatic Dis :
Tran, Phuong T; Meeker, Alan K; Platz, Elizabeth A (2018) Association between statin drug use and peripheral blood leukocyte telomere length in the National Health and Nutrition Examination Survey 1999-2002: a cross-sectional study. Ann Epidemiol 28:529-534
Pallavajjala, Aparna; Kim, Daehwan; Li, Tongbin et al. (2018) Genomic characterization of chromosome translocations in patients with T/myeloid mixed-phenotype acute leukemia. Leuk Lymphoma 59:1231-1238
Dean, Lorraine T; Moss, Shadiya L; Ransome, Yusuf et al. (2018) ""It still affects our economic situation"": long-term economic burden of breast cancer and lymphedema. Support Care Cancer :
Song, Mingyang; Vogelstein, Bert; Giovannucci, Edward L et al. (2018) Cancer prevention: Molecular and epidemiologic consensus. Science 361:1317-1318
Weber, Kari A; Heaphy, Christopher M; Joshu, Corinne E et al. (2018) Racial differences in maternal and umbilical cord blood leukocyte telomere length and their correlations. Cancer Causes Control 29:759-767
Haffner, Michael C; Taheri, Diana; Luidy-Imada, Eddie et al. (2018) Hypomethylation, endogenous retrovirus expression, and interferon signaling in testicular germ cell tumors. Proc Natl Acad Sci U S A 115:E8580-E8582
Nauman, Gina; Gray, Javaughn Corey; Parkinson, Rose et al. (2018) Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials. Antioxidants (Basel) 7:

Showing the most recent 10 out of 2393 publications